Wikidata

(Q61980524)

English

Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)

clinical trial

In more languages

Statements

title
A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the Cyclin-Dependent Kinase (CDK) Inhibitor SCH 727965 Administered Every 3 Weeks in Subjects With Advanced Malignancies (English)
0 references
start time
11 October 2006
0 references
end time
22 February 2010
0 references
number of participants
81
0 references
research intervention
(RS)-cyclophosphamide
0 references
dexamethasone acetate
0 references
ondansetron
0 references
aprepitant
0 references
fosaprepitant
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61980524&oldid=2092981260"